4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Contineum Therapeutics, Inc. (CTNM) operates in the Biotechnology industry and is headquartered in San Diego, United States with about 51 employees. Its market capitalization is roughly $547 million. In the fiscal year ended 2025-12-31, CTNM reported $0M in revenue and ($60M) in net income.
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $50M | $0M | — |
| Operating Income (EBIT) | ($68M) | ($51M) | $16M | ($23M) | — |
| Net Income | ($60M) | ($42M) | $23M | ($24M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($17M) | ($17M) | ($15M) | ($18M) | ($18M) | — |
| Net Income | ($14M) | ($15M) | ($13M) | ($16M) | ($16M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $277M | $213M | $130M | $51M | — |
| Total Liabilities | $16M | $15M | $198M | $144M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CTNM viewer.
About TickerBase · Data methodology & sources